CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4+ T-Cell–Dependent Control of Senescence
Jana C. Mossanen(Universitätsklinikum Aachen), Frank Tacke(Charité - Universitätsmedizin Berlin), Anjali A. Roeth(Maastricht University), Christian Trautwein(TUM Klinikum), Oliver Krenkel(Boehringer Ingelheim (Germany)), Anke Liepelt(Universitätsklinikum Aachen), Alexander Wehr(Universitätsklinikum Aachen), Juliane Hermann(Universitätsklinikum Aachen), Marlene Kohlhepp(Charité - Universitätsmedizin Berlin), Felix Heymann(Universitätsklinikum Aachen), Twan Lammers(RWTH Aachen University), Joachim Jankowski(Charité - Universitätsmedizin Berlin), Ulf P. Neumann(RWTH Aachen University), Tom Luedde(Düsseldorf University Hospital), Diana Möckel(RWTH Aachen University), Nikolaus Gaßler(Ernst Abbe University of Applied Sciences Jena)
Cited by 125
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.5k
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
|Nature Reviews Gastroenterology & Hepatology|2011|1.4k
Tumor targeting via EPR: Strategies to enhance patient responses
|Advanced Drug Delivery Reviews|2018|1.2k